Liu; Hong-Wei

Patent Applications and Registrations

Patent applications and USPTO patent grants for Liu; Hong-Wei.The latest application filed is for "video signal conversion device".

Company Profile

7.7.18

Liu; Hong-Wei - New Taipei City TW
LIU; Hong-Wei - Beijing CN
Liu; Hong-Wei - New Taipei TW
Liu; Hong-Wei - Kunshan CN
Liu; Hong Wei - Jiangsu CN
LIU; Hong Wei - Changzhou CN
Liu; Hong-Wei - Chung Ho City TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Video Signal Conversion Device App 20220256113 - Cheng; Ssu-Ming ; et al.	2022-08-11
Pharmaceutical Composition And Method For Regenerating Myofibers In The Treatment Of Muscle Injuries App 20220175806 - LI; Ming ; et al.	2022-06-09
Video signal conversion device Grant 11,343,466 - Cheng , et al. May 24, 2	2022-05-24
Pharmaceutical Composition And Method For Neoangiogenesis/revascularization Useful In Treating Ischemic Heart Disease App 20220152070 - LI; Ming ; et al.	2022-05-19
Pharmaceutical Composition And Method For Neoangiogenesis/revascularization Useful In Treating Ischemic Heart Disease App 20210268010 - LI; Ming ; et al.	2021-09-02
Video Signal Conversion Device App 20210067736 - Cheng; Ssu-Ming ; et al.	2021-03-04
Video signal conversion device Grant 10,868,998 - Cheng , et al. December 15, 2	2020-12-15
Electrical assembly composed of receptacle connector and plug connector Grant 10,797,446 - Liu , et al. October 6, 2	2020-10-06
Electrical Assembly Composed Of Receptacle Connector And Plug Connector App 20200106217 - LIU; HONG-WEI ; et al.	2020-04-02
Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease App 20200101096 - Li; Ming ; et al.	2020-04-02
Pharmaceutical Composition And Method For Regenerating Myofibers In The Treatment Of Muscle Injuries App 20190358251 - Li; Ming ; et al.	2019-11-28
Video Signal Conversion Device App 20190335138 - Cheng; Ssu-Ming ; et al.	2019-10-31
Load cell wireless kit Grant 9,939,313 - Dai , et al. April 10, 2	2018-04-10
Pharmaceutical Composition And Method For Regenerating Myofibers In The Treatment Of Muscle Injuries App 20170189432 - LI; Ming ; et al.	2017-07-06
Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease App 20170095495 - Li; Ming ; et al.	2017-04-06
Electronic device and manufacturing method thereof Grant 9,521,740 - Yeh , et al. December 13, 2	2016-12-13
Pharmaceutical Composition And Method For Regenerating Myofibers In The Treatment Of Muscle Injuries App 20160058797 - LI; Ming ; et al.	2016-03-03
Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries Grant 9,155,744 - Li , et al. October 13, 2	2015-10-13
Load Cell Wireless Kit App 20150226602 - DAI; Feng ; et al.	2015-08-13
Electronic Device And Manufacturing Method Thereof App 20150109740 - YEH; Chien-Ming ; et al.	2015-04-23
Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease App 20120252744 - Li; Ming ; et al.	2012-10-04
Digital Television Signal-Receiving Device with Signal Strength Showing Function App 20090207309 - Yeh; Chien-Ming ; et al.	2009-08-20
Pharmaceutical Composition And Method For Regenerating Myofibers In The Treatment Of Muscle Injuries App 20090028959 - Li; Ming ; et al.	2009-01-29
Pharmaceutical Composition And Method For Neoangiogenesis/Revascularization Useful In Treating Ischemic Heart Diseases App 20080124388 - Li; Ming ; et al.	2008-05-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.